NATURES SUNSHINE PRODUCTS INC (NATR) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
NATR currently has 17.5M outstanding shares. with moderate dilution risk from 5.13M authorized shares representing 29.3% potential dilution. The company has minimally diluted shareholders by 0.56% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 07, 2026 |
10-Q filing | 17.5M shares outstanding |
18M | 5.1M |
| Nov 06, 2025 |
10-Q filing | 17.6M shares outstanding |
18M | 5M |
| Jul 31, 2025 |
10-Q filing | 18.4M shares outstanding |
18M | 4.2M |
| Jul 07, 2025 |
8-K filing: On June 27, 2025, Fosun Pharma sold 2,854,607 shares of Nature's Sunshine Products, Inc.'s common stock and subsequently, on June 30, 2025, the Company entered into share purchase agreements to repurchase Fosun Industrial's interests in two joint ventures for $3.9 million and $3.1 million respectively. |
18M | 4.2M |
| Jun 09, 2025 |
S-3 filing: Nature The filing is an S-3 form for Nature’s Sunshine Products, Inc. and covers the offering and resale of up to 2,854,607 common shares by a selling stockholder. The shares were acquired by the selling stockholder as a transferee from an affiliate that obtained them through a private placement or the exercise/vesting of previously issued awards. The company will not receive any proceeds from the sale. |
18M | 4.2M |
| May 06, 2025 |
10-Q filing | 18.5M shares outstanding |
18M | 1.3M |
| Mar 11, 2025 |
10-K filing | 18.6M shares outstanding |
19M | 1.2M |
| Nov 07, 2024 |
10-Q filing | 18.5M shares outstanding |
19M | 1.3M |
| Aug 08, 2024 |
10-Q filing | 18.6M shares outstanding |
19M | 1.1M |
| May 07, 2024 |
10-Q filing | 18.8M shares outstanding |
19M | 970K |
| Apr 17, 2024 |
POS AM filing: This is a POS AM filing for an offering by selling stockholders of up to 2,929,001 shares of common stock acquired through private placement or exercise/vesting of previously issued awards. The company will not receive any proceeds from the sale. |
19M | 1M |
| Mar 12, 2024 |
10-K filing | 19.1M shares outstanding |
19M | 6.4M |
| Nov 07, 2023 |
10-Q filing | 19.1M shares outstanding |
19M | 6.4M |
| Aug 09, 2023 |
10-Q filing | 19.3M shares outstanding |
19M | 6.2M |
| May 09, 2023 |
10-Q filing | 19.1M shares outstanding |
19M | 6.4M |
| Mar 16, 2023 |
10-K filing | 19.3M shares outstanding |
19M | 6.2M |
| Nov 03, 2022 |
10-Q filing | 19.2M shares outstanding |
19M | 6.3M |
| Aug 09, 2022 |
10-Q filing | 19.4M shares outstanding |
19M | 6.1M |
| May 05, 2022 |
10-Q filing | 19.6M shares outstanding |
20M | 5.9M |
| Mar 08, 2022 |
10-K filing | 19.9M shares outstanding |
20M | 5.6M |
| Nov 04, 2021 |
10-Q filing | 19.9M shares outstanding |
20M | 5.6M |
| Aug 05, 2021 |
10-Q filing | 20.0M shares outstanding |
20M | 5.5M |
| Jul 28, 2021 |
S-3/A filing: The company may offer up to $125,000,000 of various securities, and selling stockholders may offer up to 5,700,000 shares of common stock. |
20M | 5.7M |
| Jul 12, 2021 |
S-3 filing: The company is filing an S-3 to register the offering of up to $125,000,000 of common stock, preferred stock, warrants, debt securities, subscription rights and units. Selling stockholders may also offer up to 5,700,000 shares of common stock. |
20M | 5.7M |
| May 06, 2021 |
10-Q filing | 19.8M shares outstanding |
20M | 0 |
| Mar 10, 2021 |
10-K filing | 20.0M shares outstanding |
20M | 0 |
| Nov 09, 2020 |
10-Q filing | 19.5M shares outstanding |
20M | 0 |
| Aug 06, 2020 |
10-Q filing | 19.5M shares outstanding |
19M | 0 |
| May 11, 2020 |
10-Q filing | 19.5M shares outstanding |
19M | 0 |
| Mar 11, 2020 |
10-K filing | 19.3M shares outstanding |
19M | 0 |